RESEARCHMU
Micron: excellent asset, fully discounted
No argument with the business. The entry is the problem: the multiple already discounts two more years of a capex cycle that has historically run three.
The economics turn on utilisation. Fixed cost per wafer is set at the capacity decision; every point of utilisation above the planning assumption drops through at close to full incremental margin, and every point below does the reverse.
Utilisation is the tell. The company guided to a utilisation rate below its own historical planning assumption while holding the capex number flat, which sets up the operating leverage in the following year rather than this one.
The position: no call. This is a name I want to own and not at this level, so there is nothing locked here and nothing for the record to grade. If the entry improves I will say so in a piece that does carry a call.
Export controls are the risk that is not hedged here. A restriction round that removes a major end market would overwhelm the company-specific argument entirely, and there is no position size that makes that survivable.
Discussion · 0
No comments yet.